CellR4 2020; 8: e2986
DOI: 10.32113/cellr4_202012_2986

Brown adipose tissue transplantation as a promising approach for insulin-independent reversal of type 1 diabetes: animal studies and clinical perspectives

CellR4 2020; 8: e2955
DOI: 10.32113/cellr4_202010_2955

Human islet distribution during COVID-19 pandemic: the impact on diabetes research

CellR4 2020; 8: e2957
DOI: 10.32113/cellr4_202010_2957

Islet cell transplantation: the effects of COVID-19 pandemic

CellR4 2020; 8: e2943
DOI: 10.32113/cellr4_202010_2943

GLP-1 receptor agonists can reverse immunosuppression-induced beta-cell dysfunction

CellR4 2020; 8: e2945
DOI: 10.32113/cellr4_202010_2945

Involvement of gut microbiota in solid organ transplantation

CellR4 2020; 8: e2939
DOI: 10.32113/cellr4_202010_2939

Mesenchymal stem cell-derived exosomes for the treatment of pulmonary diseases

CellR4 2020; 8: e2898
DOI: 10.32113/cellr4_20209_2898

The new antidiabetic agents: cardiovascular and renal protection in post-transplant diabetes mellitus

CellR4 2020; 8: e2894
DOI: 10.32113/cellr4_20209_2894

Advances in stem cell-based therapy for hair loss

CellR4 2020; 8: e2879
DOI: 10.32113/cellr4_20207_2879

Favorable effects of omega-3 PUFAs on glucose control in an adolescent with type 1 diabetes using continuous glucose monitoring: a case report

CellR4 2020; 8: e2877
DOI: 10.32113/cellr4_20207_2877

Adipose tissue browning for the treatment of obesity and metabolic diseases